189 related articles for article (PubMed ID: 10391113)
1. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
Cross JT; Benton HP
Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
Llorente L; Zou W; Levy Y; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Morel-Fourrier B; Brouet JC; Alarcon-Segovia D; Galanaud P; Emilie D
J Exp Med; 1995 Mar; 181(3):839-44. PubMed ID: 7869046
[TBL] [Abstract][Full Text] [Related]
3. [Cytokines and lupus].
Emilie D; Llorente L; Galanaud P
Ann Med Interne (Paris); 1996; 147(7):480-4. PubMed ID: 9092358
[TBL] [Abstract][Full Text] [Related]
4. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
5. Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
Dolff S; Abdulahad WH; Bijl M; Kallenberg CG
Lupus; 2009 Jun; 18(7):575-80. PubMed ID: 19433456
[TBL] [Abstract][Full Text] [Related]
6. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
7. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
8. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus.
Geginat J; Vasco M; Gerosa M; Tas SW; Pagani M; Grassi F; Flavell RA; Meroni P; Abrignani S
Semin Immunol; 2019 Aug; 44():101330. PubMed ID: 31735515
[TBL] [Abstract][Full Text] [Related]
9. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
10. Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
Pan HF; Leng RX; Tao JH; Li XP; Ye DQ
Lupus; 2011 Mar; 20(3):227-30. PubMed ID: 21362749
[TBL] [Abstract][Full Text] [Related]
11. T helper cell subsets in the pathogenesis of systemic lupus erythematosus.
Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S
Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356
[TBL] [Abstract][Full Text] [Related]
12. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y
J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
[TBL] [Abstract][Full Text] [Related]
14. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
Beebe AM; Cua DJ; de Waal Malefyt R
Cytokine Growth Factor Rev; 2002; 13(4-5):403-12. PubMed ID: 12220553
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines in systemic lupus erythematosus].
Robak E; Sysa-Jedrzejowska A; Robak T
Przegl Lek; 1996; 53(8):623-6. PubMed ID: 8999465
[TBL] [Abstract][Full Text] [Related]
16. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
17. B cell biology: implications for treatment of systemic lupus erythematosus.
Anolik JH
Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
[TBL] [Abstract][Full Text] [Related]
18. Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus.
Sim JH; Kim HR; Chang SH; Kim IJ; Lipsky PE; Lee J
Arthritis Res Ther; 2015 Jul; 17(1):190. PubMed ID: 26209442
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
Vadasz Z; Toubi E
Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653
[TBL] [Abstract][Full Text] [Related]
20. [Interleukin 10 in disseminated lupus erythematosus].
Emilie D
J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
